title: An evaluation of the impact of a single-dose intravenous immunoglobulin regimen in the treatment of Clostridium difficile infections.
authors.forename: Mamoon A
authors.initials: MA
authors.lastname: Aldeyab
authors.forename: James C
authors.initials: JC
authors.lastname: McElnay
authors.forename: Michael G
authors.initials: MG
authors.lastname: Scott
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Davies
authors.forename: Collette
authors.initials: C
authors.lastname: Edwards
authors.forename: Feras W
authors.initials: FW
authors.lastname: Darwish Elhajji
authors.forename: Geraldine
authors.initials: G
authors.lastname: Conlon
authors.forename: Fidelma A
authors.initials: FA
authors.lastname: Magee
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Barr
authors.forename: Mary P
authors.initials: MP
authors.lastname: Kearney
mesh_terms: D000369:Aged, 80 and over; D001427:Bacterial Toxins / Q000097:blood; D016360:Clostridioides difficile; D003015:Clostridium Infections / Q000188:drug therapy*; D004768:Enterotoxins / Q000097:blood; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage* / Q000627:therapeutic use; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000627:therapeutic use; D007902:Length of Stay; D008297:Male; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D001427:Bacterial Toxins; D004768:Enterotoxins; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; C041348:tcdA protein, Clostridium difficile